YiChang opens for orders on HK listing
YiChang HEC ChangJiang Pharmaceutical Co has opened books for a float of HK$1.67bn ($215m), kicking off the process with a renowned pharma investor among the cornerstones.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: